93 related articles for article (PubMed ID: 6895415)
1. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
[TBL] [Abstract][Full Text] [Related]
2. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
3. Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
Ferrant A; Hamoir V; Binon J; Michaux JL; Sokal G
Cancer; 1985 Jan; 55(2):317-22. PubMed ID: 2578082
[TBL] [Abstract][Full Text] [Related]
4. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
5. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Sarris AH; Hagemeister FB; Barista I; Hess MA; Cabanillas F; Cox JD
Cancer; 2002 Dec; 95(12):2534-8. PubMed ID: 12467067
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Hodgkin's disease.
Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM
J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795
[TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
Hagemeister FB; Fuller LM; Sullivan JA; Johnston D; North L; Butler JJ; Velasquez WS; Shullenberger CC
Cancer; 1982 Dec; 50(11):2307-13. PubMed ID: 6754064
[TBL] [Abstract][Full Text] [Related]
8. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
Baillet F; Brun B; Mazeron JJ; Rochant H; Pinon G; Reyes F; Vernant JP; Pierquin B; Dreyfus B
Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
[TBL] [Abstract][Full Text] [Related]
11. Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
Grigoraki V; Lilienthal F; Touboul E; Gabarre J; Binet JL; Merle-Béral H
Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):437-45. PubMed ID: 8414965
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
Specht L; Nissen NI; Walbom-Jørgensen S
Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
[TBL] [Abstract][Full Text] [Related]
13. Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Hakvoort-Cammel FG; Buitendijk S; van den Heuvel-Eibrink M; Hählen K
Pediatr Blood Cancer; 2004 Jul; 43(1):8-16. PubMed ID: 15170884
[TBL] [Abstract][Full Text] [Related]
14. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in children with Hodgkin disease.
Celkan T; Yildiz I
Pediatr Blood Cancer; 2008 Nov; 51(5):712; author reply 712-3. PubMed ID: 18668513
[No Abstract] [Full Text] [Related]
16. The prognostic significance of large mediastinal masses in the treatment of Hodgkin's disease. The experience of the Institut Gustave-Roussy.
Cosset JM; Henry-Amar M; Carde P; Clarke D; Le Bourgeois JP; Tubiana M
Hematol Oncol; 1984; 2(1):33-43. PubMed ID: 6376317
[TBL] [Abstract][Full Text] [Related]
17. Current trend in the treatment of Hodgkin's disease.
Tubiana M; Amiel JL; Hayat M; Henry-Amar M; Cosset JM; Droz JP; Carde P
Radiat Med; 1983; 1(3):221-9. PubMed ID: 6390537
[TBL] [Abstract][Full Text] [Related]
18. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
Fuller LM; Hagemeister FB; North LB; McLaughlin P; Velasquez WS; Cabanillas F
Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):683-92. PubMed ID: 3280532
[TBL] [Abstract][Full Text] [Related]
20. Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
Ryoo MC; Kagan AR; Wollin M; Nussbaum H; Chan PY; Hintz BL; Rao AR; McMahon J
Am J Clin Oncol; 1987 Jun; 10(3):185-93. PubMed ID: 3591736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
